An Effective Epigenetic-Parp Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

Frontiers in Oncology
Cancer ResearchOncology
2014English

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

PARP Inhibitors: Extending Benefit Beyond BRCA Mutant Cancers

Clinical Cancer Research
Cancer ResearchOncology
2019English

A Unique Subset of Epithelial Ovarian Cancers With Platinum Sensitivity and PARP Inhibitor Resistance

Cancer Research
Cancer ResearchOncology
2015English

Search for an Effective Combination of Examination Methods for Detection of Breast Cancers at Screening

Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening)
2015English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Searching for Microsatellite Mutations in Coding Regions in Lung, Breast, Ovarian and Colorectal Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Nectin-2 Is a Potential Target for Antibody Therapy of Breast and Ovarian Cancers

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

The Spectrum of BRCA Mutations and Characteristics of BRCA-associated Breast Cancers in China: Screening of 2,991 Patients and 1,043 Controls by Next-Generation Sequencing

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy